Home
Scholarly Works
Primary Analysis of Juliet: A Global, Pivotal,...
Conference

Primary Analysis of Juliet: A Global, Pivotal, Phase 2 Trial of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Authors

Schuster SJ; Bishop MR; Tam CS; Waller EK; Borchmann P; McGuirk JP; Jaeger U; Jaglowski S; Andreadis C; Westin JR

Volume

130

Publisher

AMER SOC HEMATOLOGY

Publication Date

December 7, 2017

Name of conference

59th Annual Meeting of the American-Society-of-Hematology (ASH)

Conference place

GA, Atlanta

Conference start date

December 9, 2017

Conference end date

December 12, 2017

Conference proceedings

BLOOD

ISSN

0006-4971

Contact the Experts team